UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non-Small Cell Lung Cancer

Clinical cancer research, 2017-07, Vol.23 (14), p.3585-3591

2017

Volltextzugriff (PDF)

Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma

Diagnostic pathology, 2016-10, Vol.11 (1), p.95-95, Article 95

2016

Volltextzugriff (PDF)

Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark

PloS one, 2023-04, Vol.18 (4), p.e0284037-e0284037

2023

Volltextzugriff (PDF)

EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)

American journal of cancer research, 2015-01, Vol.5 (9), p.2892-2911

2015

Volltextzugriff (PDF)

PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review

Lung cancer (Amsterdam, Netherlands), 2017-10, Vol.112, p.200-215

2017

Volltextzugriff (PDF)

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Cancer management and research, 2019-01, Vol.11, p.9469-9481

2019

Volltextzugriff (PDF)

Abstract LB-094: A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-094-LB-094

2016

Volltextzugriff (PDF)

Abstract 5530: PD-L1 expression in patients screened for phase 2 head and neck squamous cell carcinoma clinical studies (HAWK and CONDOR)

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5530-5530

2018

Volltextzugriff (PDF)

PD-L1 expression in advanced NSCLC: Primary lesions versus metastatic sites and impact of sample age

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3025-3025

2016

Volltextzugriff (PDF)

Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy

Journal of medicinal chemistry, 2017-04, Vol.60 (7), p.3187-3197

2017

Volltextzugriff (PDF)

Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark

Cancer epidemiology, 2021-08, Vol.73, p.101976-101976, Article 101976

2021

Volltextzugriff (PDF)

Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark

PloS one, 2023-01, Vol.18 (4), p.e0284037

2023

Volltextzugriff (PDF)

Development of a PD-L1 companion diagnostic assay for treatment with MEDI4736 in NSCLC and SCCHN patients

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8033-8033

2015

Volltextzugriff (PDF)

P1.01-042 Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S475-S476

2017

Volltextzugriff (PDF)

P1.01-042 Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer: Topic: Prognostic Factors, Treatment

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S475-S476

2017

Volltextzugriff (PDF)

Abstract B004: The importance of quality standards to support test performance for the purpose of treatment decision making

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B004-B004

2016

Volltextzugriff (PDF)

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-I Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Cancer management and research, 2019-11, p.9469

2019

Volltextzugriff (PDF)

Abstract B005: An immunohistochemical PD-L1 companion diagnostic assay for treatment with durvalumab (MEDI4736) in NSCLC patients

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B005-B005

2016

Volltextzugriff (PDF)

Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy

Journal of medicinal chemistry, 2017-04, Vol.60 (7), p.3187-3197

2017

Volltextzugriff (PDF)

Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma

Blood cancer journal (New York), 2024-08, Vol.14 (1), p.137-4, Article 137

2024

Volltextzugriff (PDF)

Multilocus sequence analysis reveals high genetic diversity in clinical isolates of Burkholderia cepacia complex from India

Scientific reports, 2016-10, Vol.6 (1), p.35769-35769, Article 35769

2016

Volltextzugriff (PDF)

Secondary infections modify the overall course of hospitalized patients with COVID-19: a retrospective study from a network of hospitals across North India

IJID regions, 2022-06, Vol.3, p.44-53

2022

Volltextzugriff (PDF)

Traumatic Endophthalmitis due to Cellulosimicrobium cellulans

Case reports in ophthalmological medicine, 2011-01, Vol.2011 (2011), p.1-3

2011

Volltextzugriff (PDF)

HCC surveillance results in earlier HCC detection: results from an Indian cohort

SpringerPlus, 2014-10, Vol.3 (1), p.610-5, Article 610

2014

Volltextzugriff (PDF)

Traumatic Endophthalmitis due to Cellulosimicrobium cellulans

Case reports in ophthalmological medicine, 2011, Vol.2011, p.469607-469607

2011

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(10)
Apoptosis
(6)
Humans
(6)
Oncology
(6)
Cell Death
(5)
Lung Cancer
(5)
Immunotherapy
(4)
Ligands
(4)
Patients
(4)
Tumors
(4)
Biomarkers
(3)
Cancer
(3)
Carcinoma, Non-Small-Cell Lung - Pathology
(3)
Chemotherapy
(3)
Epidemiology
(3)
Medical Prognosis
(3)
Multidisciplinary Sciences
(3)
Mutation
(3)
Non-Small Cell Lung Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non-Small Cell Lung Cancer

Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma

Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark

EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)

PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Abstract LB-094: A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative

Abstract 5530: PD-L1 expression in patients screened for phase 2 head and neck squamous cell carcinoma clinical studies (HAWK and CONDOR)

PD-L1 expression in advanced NSCLC: Primary lesions versus metastatic sites and impact of sample age

Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy

Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark

Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark

Development of a PD-L1 companion diagnostic assay for treatment with MEDI4736 in NSCLC and SCCHN patients

P1.01-042 Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer

P1.01-042 Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer: Topic: Prognostic Factors, Treatment

Abstract B004: The importance of quality standards to support test performance for the purpose of treatment decision making

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-I Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Abstract B005: An immunohistochemical PD-L1 companion diagnostic assay for treatment with durvalumab (MEDI4736) in NSCLC patients

Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy

Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma

Multilocus sequence analysis reveals high genetic diversity in clinical isolates of Burkholderia cepacia complex from India

Secondary infections modify the overall course of hospitalized patients with COVID-19: a retrospective study from a network of hospitals across North India

Traumatic Endophthalmitis due to Cellulosimicrobium cellulans

HCC surveillance results in earlier HCC detection: results from an Indian cohort

Traumatic Endophthalmitis due to Cellulosimicrobium cellulans

Suchergebnisse filtern